These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24112226)

  • 1. Tear fluid biomarker profiling: a review of multiplex bead analysis.
    Hagan S; Tomlinson A
    Ocul Surf; 2013 Oct; 11(4):219-35. PubMed ID: 24112226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
    Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
    Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear osmolarity as a biomarker for dry eye disease severity.
    Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular biomarkers in dry eye disease and ocular allergy.
    Enríquez-de-Salamanca A; Bonini S; Calonge M
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):523-33. PubMed ID: 22895048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
    Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
    J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests.
    VanDerMeid KR; Su SP; Ward KW; Zhang JZ
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1512-8. PubMed ID: 22323462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
    Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles.
    Balne PK; Au VB; Tong L; Ghosh A; Agrawal M; Connolly J; Agrawal R
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29053687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of inflammatory cytokines in the tears of dry eye patients.
    Massingale ML; Li X; Vallabhajosyula M; Chen D; Wei Y; Asbell PA
    Cornea; 2009 Oct; 28(9):1023-7. PubMed ID: 19724208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of time between collection and collection method on human tear fluid osmolarity.
    Keech A; Senchyna M; Jones L
    Curr Eye Res; 2013 Apr; 38(4):428-36. PubMed ID: 23402632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between the tear film lipid layer and dry eye disease.
    Foulks GN
    Surv Ophthalmol; 2007; 52(4):369-74. PubMed ID: 17574063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.
    Wei Y; Gadaria-Rathod N; Epstein S; Asbell P
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8327-36. PubMed ID: 24204044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the tear film and ocular surface from dry eye syndrome.
    Johnson ME; Murphy PJ
    Prog Retin Eye Res; 2004 Jul; 23(4):449-74. PubMed ID: 15219877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions.
    López-Miguel A; Tesón M; Martín-Montañez V; Enríquez-de-Salamanca A; Stern ME; Calonge M; González-García MJ
    Am J Ophthalmol; 2014 Apr; 157(4):788-798.e2. PubMed ID: 24412126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in using signs and symptoms to evaluate new biomarkers of dry eye disease.
    Sullivan B
    Ocul Surf; 2014 Jan; 12(1):2-9. PubMed ID: 24439041
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects.
    Benito MJ; González-García MJ; Tesón M; García N; Fernández I; Calonge M; Enríquez-de-Salamanca A
    Exp Eye Res; 2014 Mar; 120():43-9. PubMed ID: 24412438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
    Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
    Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tear lipocalin and lysozyme concentrations in postmenopausal women.
    Srinivasan S; Joyce E; Boone A; Simpson T; Jones L; Senchyna M
    Ophthalmic Physiol Opt; 2010 May; 30(3):257-66. PubMed ID: 20444132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.